ArticleBreast cancer (Tokyo, Japan)2024

SLC38A5 promotes glutamine metabolism and inhibits cisplatin chemosensitivity in breast cancer.

Xiaowei Shen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.